Neural Therapy and Kinesio Taping Effectiveness in Fibromyalgia
The Effects of Neural Therapy and Kinesio Taping on Pain, Functional Status, and Quality of Life in Fibromyalgia Patients: A Prospective Randomized Double-Blind Study
1 other identifier
interventional
65
1 country
2
Brief Summary
The aim of this study; to investigate the effects of neural therapy and kinesio taping treatments on pain, functional status and quality of life in women with fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 6, 2022
CompletedFirst Posted
Study publicly available on registry
November 18, 2022
CompletedNovember 18, 2022
November 1, 2022
8 months
August 6, 2022
November 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Visual Analogue Scale pain (0-10 point).
Higher scores mean a worse outcome
up to 3 month
Fibromyalgia Impact Questionnaire (0-100 point)
The Fibromyalgia Impact Questionnaire was developed to assess the current functional status of women with FMS. Higher scores mean a worse outcome
up to 3 month
Pain measurement with manual algometer
18 tender points in 1990 ACR FMS criteria will be evaluated with a manual algometer. Higher scores mean a worse outcome
up to 3 month
Secondary Outcomes (5)
Beck Depression Inventory (0-63 point)
up to 3 month
Beck Anxiety Inventory (0-63 point)
up to 3 month
Central Sensitisation Inventory (0-100 point)
up to 3 month
Health Assessment Questionnaire (0-60 point)
up to 3 month
Short Form-36 (0-100 point)
up to 3 month
Study Arms (2)
Neural Therapy
ACTIVE COMPARATORSegmental neural therapy will be administered with intradermal 0.5% lidocaine from cervical 1st to sacral 1st vertebra and upper trapezius region with quaddel injections.. Sham kinesio taping will be applied to the bilateral arms of the patients. Home exercise program; trapezius stretching, cervical, thoracic and lumbar paravertebral muscle stretching exercises will be required to be performed 10 times and every day.
Kinesio Taping
ACTIVE COMPARATORKinesio taping will be applied with muscle inhibition technique by stretching from the origin to the insertion of the upper trapezius, cervical thoracic and lumbar paravertebral muscles. Sham neural therapy will be applied to the bilateral arms of the patients. Home exercise program; trapezius stretching, cervical, thoracic and lumbar paravertebral muscle stretching exercises will be required to be performed 10 times and every day.
Interventions
Neural therapy is a form of treatment that aims to act on the autonomic nervous system, by injecting local anesthetics into certain parts of the body.
Kinesiotape is used for injury prevention, rehabilitation and performance enhancement. It has been shown to be clinically effective in increasing joint movements, increasing muscle activity, inducing muscle maximum torque earlier, and improving functional performance
Eligibility Criteria
You may qualify if:
- To be diagnosed with fibromyalgia according to the ACR 2016 diagnostic criteria.
- Being a woman between the ages of 18 and 55.
- No change in the medical treatment he received for fibromyalgia syndrome during the study
- To be able to come to treatment 1 day a week for 6 weeks
You may not qualify if:
- Presence of known central nervous system or peripheral nervous system disease, progressive neurological deficit
- Peripheral venous insufficiency, coagulopathies and anticoagulant drug use
- Loss of sensation, loss of position sense, unhealed fracture or open surgical wound
- Uncontrolled hypertension and uncontrolled diabetes
- Be in major depression
- Cognitive impairment that causes difficulty following simple commands
- Pregnancy
- Be in menopause
- Allergy to local anesthetics and kinesio taping
- Open wound or infection at the application site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Istanbul, Fatıh, 34034, Turkey (Türkiye)
Istanbul University
Istanbul, 3409, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşegül Ketenci, Professor
Study Director
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 6, 2022
First Posted
November 18, 2022
Study Start
March 1, 2021
Primary Completion
November 1, 2021
Study Completion
January 1, 2022
Last Updated
November 18, 2022
Record last verified: 2022-11